ACTIVE SUBSTANCE / INN

LITHIUM CARBONATE

Brand name(s): LITHONATE, ESKALITH CR, LITHANE, LITHOTABS, LITHIUM CARBONATE, ESKALITH, LITHOBID
FDA LISTED
PRESCRIPTION
DISCONTINUED
NDA017971
ANDA076243
ACTIVE SUBSTANCE
Lithium Carbonate
REGULATORS
FDA
SPONSORS / MAH
JDS PHARMS, PHARMOBEDIENT, BAYER PHARMS
TOTAL APPLICATIONS
8
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LITHIUM CARBONATEANDA076243PHARMOBEDIENTDiscontinued
LITHONATENDA016782SOLVAYDiscontinued
LITHIUM CARBONATEANDA076832HIKMAPrescription
LITHANENDA018833BAYER PHARMSDiscontinued
ESKALITHNDA017971JDS PHARMSDiscontinued
LITHOBIDNDA018027ANI PHARMSPrescription
LITHOTABSNDA016980SOLVAYDiscontinued
ESKALITH CRNDA018152JDS PHARMSDiscontinued

FULL INTELLIGENCE ON LITHIUM CARBONATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →